Deutsche Bank CEO Sewing: Can imagine joining defense bank

Deutsche Bank CEO Sewing: Can imagine joining defense bank

Deutsche Bank has reportedly initiated the process of divesting its retail banking operations in India, according to Reuters [2]. The bank has reached out to both domestic and international financial institutions to solicit bids for its retail assets, marking a move as it joins other foreign banks in reassessing their presence in the Indian market. The bank's retail division in India operates across 17 branches, and the deadline for non-binding bids has been set for August 29, although details regarding the bids and the valuation of the retail business remain undisclosed.

The decision comes amidst a challenging landscape for foreign banks in India. Despite the increasing number of affluent individuals, competition from local banks and regulatory hurdles have posed significant challenges. Previous attempts by other banks to exit the Indian retail sector include Citibank's sale of its credit card and retail businesses in 2022 for over $1 billion and Standard Chartered's divestment of its personal loan portfolio to Kotak Mahindra Bank.

In a separate development, Deutsche Bank analysts have upgraded their recommendation for Sanofi shares from "hold" to "buy," citing optimism over amlitelimab, a new treatment for atopic dermatitis [1]. The upgrade reflects growing optimism among investors about Sanofi's ability to diversify its revenue streams and mitigate the risks associated with the expiration of its flagship drug's patent.

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3UP06J:0-db-upgrades-sanofi-to-buy-on-eczema-drug-potential/
[2] https://finance.yahoo.com/news/deutsche-bank-reportedly-initiates-sale-115244543.html